Papanicolaou smears by the Bethesda system in endometrial malignancy: Utility and prognostic importance

Obstetrics and Gynecology

Volumn 90, Issue 6, 1997, Pages 999-1003

  Eddy, Gary L ^a   Wojtowycz, Martha A ^a   Piraino, Pamela S ^b   Mazur, Michael T ^b  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b CROUSE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER GRADING; CARCINOSARCOMA; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CYTOLOGY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK; VAGINAL SMEARS;

EID: 0030704611     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00548-6     Document Type: Article

References (11)

1. DuBeshter B, Warshal DP, Angel C, Dvoretsky PM, Lin JL, Raubertas RF. Endometrial carcinoma The relevance of cervical cytology . Obstet Gynecol. 77:1991;458-462.
2. Mitchell H, Giles G, Medley G. Accuracy and survival benefit of cytologic prediction of endometrial carcinoma on routine cervical smears. Int J Gynecol Pathol. 12:1993;34-40.
3. Larson DM, Johnson KK, Reyes CN Jr, Broste SK. Prognostic significance of malignant cervical cytology in patients with endometrial cancer. Obstet Gynecol. 84:1994;399-403.
4. Demirkiran F, Arvas M, Erkun E, Kosebay D, Isiloglu H, Aktas E, et al. The prognostic significance of cervico-vaginal cytology in endometrial cancer. Eur J Gynaecol Oncol. 16:1995;403-409.
5. Kurman RJ, Solomon D. The Bethesda system for reporting cervical/vaginal cytologic diagnoses Definitions, criteria and explanatory notes for terminology and specimen adequacy . 1994;Springer-Verlag, New York.
6. Eddy GL, Strumpf KB, Wojtowycz MA, Piraino P, Mazur MI. Biopsy findings in 531 patients with atypical glandular cells of uncertain significance (AGCUS) as defined by the Bethesda system (TBS). Am J Obstet Gynecol. 177:1997;1188-1195.
7. Creasman WT. New gynecologic cancer staging. Obstet Gynecol. 75:1990;287-288.
8. Burk JR, Lehman HF, Wolf FS. Inadequacy of Papanicolaou smears in the detection of endometrial cancer. N Engl J Med. 291:1974;191-192.
9. Cherkis RC, Patten SF Jr, Dickinson JC, Dekanich AS. Significance of atypical endometrial cells detected by cervical cytology. Obstet Gynecol. 69:1987;786-789.
10. Zucker PK, Kasdon EJ, Feldstein MI. The validity of Pap smear parameters as predictors of endometrial pathology in menopausal women. Cancer. 56:1985;2256-2263.
11. Kennedy AW, Salmieri SS, Wirth SL, Biscotti CV, Tuason LJ, Travarca MJ. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening. Gynecol Oncol. 63:1996;14-18.